Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

News Daily News

Sexual Minorities See Sharpest Impact of SDOH on CV Health

Caitlin E. Cox

February 07, 2025

News Opinion Off Script

This Women’s History Month, Let’s Make More Women’s Histories Possible

Annabelle Santos Volgman, MD

March 12, 2024

News Conference News AHA 2022

Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI

L.A. McKeown

November 07, 2022

News Daily News

STRONG-HF: Fast Optimal GDMT Cuts Deaths, Hospitalizations in Acute HF

Shelley Wood

October 17, 2022

News Daily News

FDA Proposes Ban on Menthol Cigarettes and Flavored Cigars

Michael O'Riordan

April 28, 2022

News

COVID-19: TCTMD’s Daily Dispatch for November

Todd Neale

November 01, 2020

News Daily News

Pricey, Unproven ‘Executive’ CVD Screening the Norm at Top US Hospitals

Michael O'Riordan

January 16, 2020

News Daily News

Midlife Hypertension Linked to Late-Life Cognitive Decline

Leah Lawrence

October 11, 2016

News Industry News

FDA Approves First And Only Single Monthly Injection For A PCSK9 Inhibitor

July 11, 2016

News Industry News

Novartis' new heart failure medicine LCZ696 approved by FDA to reduce risk of cardiovascular death and heart failure hospitalization; now called Entresto™ (sacubitril-valsartan)

July 07, 2015

News Industry News

The New England Journal of Medicine publishes LEVANT 2 results for the Lutonix® Drug Coated Balloon, showing superior efficacy compared to standard PTA

June 25, 2015

News Industry News

Sunshine Heart Receives FDA Approval for Interim Analysis of U.S. Pivotal Trial of C-Pulse(R) Heart Assist System

February 24, 2015

News Industry News

Boston Scientific Begins International Launch and First Implants of Next-Generation Devices to Treat Heart Failure and Sudden Cardiac Death

May 06, 2011

Advertisement

Sexual Minorities See Sharpest Impact of SDOH on CV Health

This Women’s History Month, Let’s Make More Women’s Histories Possible

Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI

STRONG-HF: Fast Optimal GDMT Cuts Deaths, Hospitalizations in Acute HF

FDA Proposes Ban on Menthol Cigarettes and Flavored Cigars

COVID-19: TCTMD’s Daily Dispatch for November

Pricey, Unproven ‘Executive’ CVD Screening the Norm at Top US Hospitals

Midlife Hypertension Linked to Late-Life Cognitive Decline

FDA Approves First And Only Single Monthly Injection For A PCSK9 Inhibitor

Novartis' new heart failure medicine LCZ696 approved by FDA to reduce risk of cardiovascular death and heart failure hospitalization; now called Entresto™ (sacubitril-valsartan)

The New England Journal of Medicine publishes LEVANT 2 results for the Lutonix® Drug Coated Balloon, showing superior efficacy compared to standard PTA

Sunshine Heart Receives FDA Approval for Interim Analysis of U.S. Pivotal Trial of C-Pulse(R) Heart Assist System

Boston Scientific Begins International Launch and First Implants of Next-Generation Devices to Treat Heart Failure and Sudden Cardiac Death

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content